Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedApr 02, 2026
DataAggregated Company Financials
Companies227
  • 7D-0.9%
  • 3M-7.1%
  • 1Y-2.0%
  • YTD-6.9%

The Healthcare is pretty flat in the last 7 days, but Caliway Biopharmaceuticals has stood out, gaining 11%. Furthermore, the industry has been flat for the past year as well. Looking forward, earnings are forecast to grow by 60% annually.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 02 Apr 2026NT$1.6tNT$270.0bNT$17.7b18.9x89.5x5.9x
Sat, 28 Feb 2026NT$1.9tNT$269.1bNT$11.7b18.7x157.7x6.9x
Mon, 26 Jan 2026NT$1.8tNT$268.8bNT$13.4b19.4x134.3x6.7x
Wed, 24 Dec 2025NT$1.7tNT$267.4bNT$13.7b19.1x124.6x6.4x
Fri, 21 Nov 2025NT$1.6tNT$267.8bNT$12.9b20.2x125.3x6x
Sun, 19 Oct 2025NT$1.8tNT$266.8bNT$8.4b21.5x210.7x6.6x
Tue, 16 Sep 2025NT$1.8tNT$266.1bNT$8.6b22.7x211.7x6.8x
Thu, 14 Aug 2025NT$1.6tNT$264.2bNT$12.3b21.7x133.6x6.2x
Sat, 12 Jul 2025NT$1.6tNT$261.0bNT$16.4b20.2x97.3x6.1x
Mon, 09 Jun 2025NT$1.5tNT$260.9bNT$16.3b19.4x95x5.9x
Wed, 07 May 2025NT$1.4tNT$255.6bNT$12.4b19.7x114.7x5.6x
Fri, 04 Apr 2025NT$1.5tNT$254.3bNT$12.1b21.8x125.5x5.9x
Sun, 02 Mar 2025NT$1.7tNT$249.6bNT$10.9b23.8x152.6x6.6x
Tue, 28 Jan 2025NT$1.5tNT$246.2bNT$8.7b22.2x175.5x6.2x
Thu, 26 Dec 2024NT$1.5tNT$245.0bNT$8.6b21.9x172.3x6x
Sat, 23 Nov 2024NT$1.5tNT$244.5bNT$9.0b23x165.6x6.1x
Mon, 21 Oct 2024NT$1.5tNT$236.4bNT$6.8b24.6x225.1x6.4x
Wed, 18 Sep 2024NT$1.6tNT$236.2bNT$7.0b24.6x225x6.7x
Fri, 16 Aug 2024NT$1.6tNT$233.9bNT$6.7b26.6x239.9x6.9x
Sun, 14 Jul 2024NT$1.6tNT$229.1bNT$3.7b28.6x441.9x7.2x
Tue, 11 Jun 2024NT$1.5tNT$228.6bNT$3.9b27.3x393x6.7x
Thu, 09 May 2024NT$1.5tNT$229.3bNT$4.4b25.6x329.8x6.3x
Sat, 06 Apr 2024NT$1.5tNT$228.5bNT$6.0b27x252.6x6.7x
Mon, 04 Mar 2024NT$1.5tNT$227.0bNT$6.5b25.5x227.5x6.5x
Wed, 31 Jan 2024NT$1.4tNT$225.3bNT$6.1b24.9x225.8x6.1x
Fri, 29 Dec 2023NT$1.4tNT$225.0bNT$6.0b25.5x233.6x6.3x
Sun, 26 Nov 2023NT$1.4tNT$224.7bNT$5.9b24.6x238.8x6.2x
Tue, 24 Oct 2023NT$1.3tNT$225.3bNT$8.3b24.4x160x5.9x
Thu, 21 Sep 2023NT$1.4tNT$225.2bNT$8.2b25.7x167.3x6.1x
Sat, 19 Aug 2023NT$1.4tNT$225.3bNT$8.2b24.3x165.7x6x
Mon, 17 Jul 2023NT$1.4tNT$226.5bNT$11.6b25.5x121.9x6.2x
Wed, 14 Jun 2023NT$1.4tNT$225.0bNT$11.1b24.5x128.5x6.3x
Fri, 12 May 2023NT$1.4tNT$220.2bNT$12.1b23.9x116.9x6.4x
Sun, 09 Apr 2023NT$1.5tNT$221.3bNT$12.8b23.4x114.1x6.6x
Price to Earnings Ratio

114.1x


Total Market Cap: NT$1.5tTotal Earnings: NT$12.8bTotal Revenue: NT$221.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 190.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 89.5x which is lower than its 3-year average PE of 191x.
  • The industry is trading close to its 3-year average PS ratio of 6.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 12% per year over the last three years.
  • Revenues for these companies have grown 6.9% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market-0.85%
Healthcare-0.85%
Pharma0.61%
Biotech-1.02%
Healthcare Services-1.49%
Healthtech-2.20%
Life Sciences-3.17%
Medical Equipment-3.54%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 39.6x.
    • Analysts are expecting annual earnings growth of 26.4%, which is higher than its past year's earnings growth of 1.8% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 70% over the next 5 years.
  • This is better than its past earnings growth rate of 5.4% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 26% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6919 Caliway BiopharmaceuticalsNT$95.8011.9%
+NT$15.8b		22.7%PS3911.3x
6547 Medigen Vaccine BiologicsNT$58.8013.1%
+NT$2.2b		21.6%PS31.5x
1795 Lotus PharmaceuticalNT$216.003.6%
+NT$2.0b		-6.9%PE12x
1789 ScinoPharm TaiwanNT$22.658.9%
+NT$1.5b		7.3%PE130.8x
4743 Oneness BiotechNT$54.604.8%
+NT$1.2b		-22.0%PS202.3x

Latest News

6919
NT$95.80
Caliway Biopharmaceuticals
7D
11.9%
1Y
22.7%
6945
NT$201.50
AP Biosciences
7D
-5.0%
1Y
289.0%
6472
NT$449.00
Bora Pharmaceuticals
7D
-1.3%
1Y
-22.2%

6472: Renewed GSK Manufacturing Agreement Will Support Long Term Earnings Power

Analysts have inched up their price target on Bora Pharmaceuticals to NT$741.35 from NT$741.02, citing updated assumptions that combine a higher revenue growth outlook of 29.58% with a slightly stronger profit margin of 20.74% and a modestly lower future P/E of 13.69. What's in the News Bora Pharmaceuticals has scheduled a board meeting on March 11, 2026, to review the 2025 fourth quarter consolidated financial statement (Key Developments).
6976
NT$12.65
Acepodia
7D
8.1%
1Y
-31.1%
4743
NT$54.60
Oneness Biotech
7D
4.8%
1Y
-22.0%
1795
NT$216.00
Lotus Pharmaceutical
7D
3.6%
1Y
-6.9%
6547
NT$58.80
Medigen Vaccine Biologics
7D
13.1%
1Y
21.6%
7754
NT$67.90
AnnJi Pharmaceutical
7D
9.0%
1Y
244.7%
4771
NT$179.50
Vizionfocus
7D
-6.0%
1Y
-15.1%
7799
NT$341.00
Heron Neutron Medical
7D
-12.1%
1Y
-25.6%
6949
NT$562.00
Pell Bio-Med Technology
7D
-2.9%
1Y
297.2%
6446
NT$632.00
PharmaEssentia
7D
-1.7%
1Y
30.8%
1789
NT$22.65
ScinoPharm Taiwan
7D
8.9%
1Y
7.3%
7878
NT$272.50
Pharmasaga
7D
-9.3%
1Y
n/a
6535
NT$142.50
Lumosa Therapeutics
7D
-5.3%
1Y
-19.7%
6491
NT$290.00
Pegavision
7D
4.1%
1Y
-19.4%